TMO
Thermo Fisher Scientific Inc. · Healthcare · Medical - Diagnostics & Research
Toutes les données de détention : gérants 13F suivis uniquement, positions en actions ordinaires, période de référence Q2 2024
| Trimestre | Détenteurs | Δ | Actions | Valeur déclarée | Nouveau | Sorties |
|---|---|---|---|---|---|---|
| Q2 2026 | 191 | +3 | 260.61M | $131.45B | +5 | −1 |
| Q1 2026 | 190 | +2 | 255.88M | $126.62B | +7 | −6 |
| Q4 2025 | 187 | +3 | 274.75M | $159.19B | +4 | — |
| Q3 2025 | 29 | -1 | 154.46M | $74.90B | +1 | −3 |
| Q2 2025 | 28 | +3 | 123.95M | $50.25B | +3 | — |
| Q1 2025 | 22 | -2 | 60.64M | $30.17B | — | −2 |
| Q4 2024 | 24 | +2 | 61.50M | $31.99B | +2 | — |
| Q3 2024 | 21 | -2 | 44.46M | $27.48B | — | −2 |
| Q2 2024 | 23 | — | 44.78M | $24.75B | — | — |
| # | Gérant | Actions | Δ actions | Valeur | Leur poids | Détenu | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 9.93M | — | $5.49B | 0.7% | n/c | 1 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 9.93M | — | $5.49B | 0.7% | n/c | 1 | SEC ↗ |
| 3 | Capital World Investors ✦ | 9.52M | — | $5.26B | 0.9% | n/c | 1 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passif) | 7.53M | — | $4.15B | 0.4% | n/c | 1 | SEC ↗ |
| 5 | Geode Capital Management ✦ (passif) | 7.53M | — | $4.15B | 0.4% | n/c | 1 | SEC ↗ |
| 6 | Norges Bank ✦ (passif) | 5.57M | — | $3.08B | 0.5% | n/c | 1 | SEC ↗ |
| 7 | Wellington Management ✦ | 3.03M | — | $1.67B | 0.3% | n/c | 1 | SEC ↗ |
| 8 | Wellington Management ✦ | 3.03M | — | $1.67B | 0.3% | n/c | 1 | SEC ↗ |
| 9 | Wellington Management ✦ | 3.03M | — | $1.67B | 0.3% | n/c | 1 | SEC ↗ |
| 10 | Wellington Management ✦ | 3.03M | — | $1.67B | 0.3% | n/c | 1 | SEC ↗ |
| 11 | Wellington Management ✦ | 3.03M | — | $1.67B | 0.3% | n/c | 1 | SEC ↗ |
| 12 | Wellington Management ✦ | 3.03M | — | $1.67B | 0.3% | n/c | 1 | SEC ↗ |
| 13 | Wellington Management ✦ | 3.03M | — | $1.67B | 0.3% | n/c | 1 | SEC ↗ |
| 14 | Wellington Management ✦ | 3.03M | — | $1.67B | 0.3% | n/c | 1 | SEC ↗ |
| 15 | PRIMECAP Management ✦ | 2.67M | — | $1.47B | 1.1% | n/c | 1 | SEC ↗ |
| 16 | Fisher Asset Management ✦ | 2.57M | — | $1.42B | 0.6% | n/c | 1 | SEC ↗ |
| 17 | Citadel Advisors ✦ | 982.69K | — | $543.43M | 0.5% | n/c | 1 | SEC ↗ |
| 18 | Citadel Advisors ✦ | 982.69K | — | $543.43M | 0.5% | n/c | 1 | SEC ↗ |
| 19 | Baillie Gifford ✦ | 621.52K | — | $343.70M | 0.3% | n/c | 1 | SEC ↗ |
| 20 | Baillie Gifford ✦ | 621.52K | — | $343.70M | 0.3% | n/c | 1 | SEC ↗ |
| 21 | Baillie Gifford ✦ | 621.52K | — | $343.70M | 0.3% | n/c | 1 | SEC ↗ |
| 22 | Baillie Gifford ✦ | 621.52K | — | $343.70M | 0.3% | n/c | 1 | SEC ↗ |
| 23 | Millennium Management ✦ | 565.42K | — | $312.68M | 0.3% | n/c | 1 | SEC ↗ |
| 24 | Two Sigma Investments ✦ | 427.81K | — | $236.58M | 0.6% | n/c | 1 | SEC ↗ |
| 25 | Adage Capital Partners ✦ | 351.91K | — | $194.61M | 0.4% | n/c | 1 | SEC ↗ |
| 26 | Point72 Asset Management ✦ | 336.54K | — | $186.10M | 0.6% | n/c | 1 | SEC ↗ |
| 27 | Renaissance Technologies ✦ | 235.85K | — | $130.42M | 0.2% | n/c | 1 | SEC ↗ |
| 28 | D. E. Shaw & Co. ✦ | 201.26K | — | $111.30M | 0.2% | n/c | 1 | SEC ↗ |
| 29 | D. E. Shaw & Co. ✦ | 201.26K | — | $111.30M | 0.2% | n/c | 1 | SEC ↗ |
| 30 | AQR Capital Management ✦ | 98.15K | — | $54.28M | 0.1% | n/c | 1 | SEC ↗ |
| 31 | AQR Capital Management ✦ | 98.15K | — | $54.28M | 0.1% | n/c | 1 | SEC ↗ |
| 32 | AQR Capital Management ✦ | 98.15K | — | $54.28M | 0.1% | n/c | 1 | SEC ↗ |
| 33 | AQR Capital Management ✦ | 98.15K | — | $54.28M | 0.1% | n/c | 1 | SEC ↗ |
| 34 | Bridgewater Associates ✦ | 33.73K | — | $18.65M | 0.1% | n/c | 1 | SEC ↗ |
| 35 | Arrowstreet Capital ✦ | 29.95K | — | $16.56M | 0.0% | n/c | 1 | SEC ↗ |
| 36 | Markel Group ✦ | 29.40K | — | $16.26M | 0.2% | n/c | 1 | SEC ↗ |
| 37 | Dodge & Cox ✦ | 26.79K | — | $14.82M | 0.0% | n/c | 1 | SEC ↗ |
| 38 | Gotham Asset Management ✦ | 21.28K | — | $11.77M | 0.2% | n/c | 1 | SEC ↗ |
| 39 | GAMCO Investors ✦ | 4.29K | — | $2.37M | 0.0% | n/c | 1 | SEC ↗ |
| 40 | Marshall Wace ✦ | 700 | — | $387,100 | 0.0% | n/c | 1 | SEC ↗ |
« Leur pondération » = la part de la position dans la valeur des actions 13F déclarées de ce gérant — la mesure de conviction. ✦ = gérant sélectionné.
Nouveaux acheteurs
| Aucun nouvel acheteur suivi ce trimestre. |
Sorti(e)
| Aucune sortie suivie ce trimestre. |
Contexte marché global: parmi TOUS les déposants 13F (données structurées SEC, Q1 2026): 1 détenteurs, 24.30K actions, $11,944 déclaré. Il s'agit d'une période différente et plus ancienne que les chiffres de l'univers suivi ci-dessus ; les deux ne sont jamais mélangés.
Ce que les détenteurs suivis de ce titre détiennent le plus souvent par ailleurs — nombre de détentions partagées, sans relation fondamentale sous-jacente.
Achats sur le marché libre (P)
Aucun achat d'initié sur le marché libre dans notre fenêtre de couverture.
Ventes sur le marché libre (S)
Officer, Director · 321 act. · $201,941
Officer, Director · 3.01K act. · $1.89M
Officer, Director · 1.79K act. · $1.12M
Officer, Director · 2.15K act. · $1.35M
Officer, Director · 2.73K act. · $1.71M
Officer, Director · 560 act. · $354,446
Officer, Director · 80 act. · $50,719
Officer, Director · 1.31K act. · $824,745
Officer, Director · 2.60K act. · $1.64M
Officer, Director · 1.25K act. · $787,312
Les attributions, exercices et retenues fiscales ne sont jamais comptabilisés comme des achats ou des ventes ici. Méthodologie